Pharma social networking sites like Facebook and YouTube may lack patient-centered information and can also be sources of misleading information that could potentially do more harm than good.
Welcome to Volume 10, Issue #11 (21 JUNE 2011) of Pharma Marketing News.
HepC.tv is featuring the video 'Man-on-the-Street: New Yorkers' Reactions to the Big Yellow C.' Is it effective? How do we know?
According to a Bad Ad Program 2010-2011 Year End Report just issued by the FDA, the program is a success despite the fact that ONLY 125 complaints were deemed worthy of
In a recent video titled 'What Gets PhRMA's Chairman Up Every Morning?', Chris Viehbacher, CEO of Sanofi, cited an impressive Potemkin number related to life expectancy and the pharma industry.
Pharma Marketing News is the monthly e-newsletter of the Pharma Marketing Network (www.pharma-mkting.com). It is packed with facts, opinions, and case studies based upon interviews with experts in the field of pharmaceutical marketing. Highlights of presentations from industry conferences, contact lists for experts consulted, and links to references help susbcribers keep up to date on best practices and network with their peers.
Despite dire predictions of 'PR failure,' the #rxsave Twitter chat hosted by @AstraZenecaUS on 15 February 2011 was a great success, which is pharma social media speak for 'did not crash and burn.' It was proof that a pharmaceutical company can indeed host meaningful Twitter chats.
Economic Experts Disagree Wildly on How Much It Costs to Bring a New Drug to Market. How is it that the Tufts estimate is at least 14 TIMES the London School of Economics and Political Science (LSEPS) estimate? 'Make no mistake,' said Tufts. 'Tufts CSDD will vigorously defend the scholarship, integrity, and validity of all its published research studies.'
Plenty of attention being paid to pharmaceutical marketing fraud and abuse cases in blogs and in the general media. But there hasn't been much attention paid to good compliance solutions or best practices. That's the mission of the Good Promotion Practices Alliance (GPP), which is co-sponsored by Reprints Desk and Prolifiq Software.
The pharmaceutical industry has been very generous in making payments to physicians. Last year (2010), for example, a mere dozen pharmaceutical companies paid $760 million to physicians and other health care providers for consulting, speaking, research and expenses. On average, how much do you think that comes to for every physician in the U.S.?